Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
19 hedge funds and large institutions have $167K invested in Liminal BioSciences Inc. Common Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
6% more funds holding
Funds holding: 18 → 19 (+1)
33% less capital invested
Capital invested by funds: $250K → $167K (-$83.4K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$20.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$17K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$228 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$137 |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$130 |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$124 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$72 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
National Bank of Canada
Montreal,
Quebec, Canada
| $49K | -$124 | -19 | -0.2% |
|
|
2
Renaissance Technologies
New York
| $34K | +$20.2K | +3,112 | +88% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $19.1K | -$137 | -21 | -0.6% |
|
|
4
Citadel Advisors
Miami,
Florida
| $13K | +$17K | +2,617 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $11K | – | – | – |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | -$72 | -11 | -0.6% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10K | +$12.9K | +1,976 | New |
|
8
Morgan Stanley
New York
| $7K | – | – | – |
|
9
Two Sigma Advisers
New York
| $6K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $4K | +$228 | +35 | +5% |
|
|
ECM
11
Estabrook Capital Management
New York
| $2.56K | – | – | – |
|
|
IA
12
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
TWC
13
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $42 | -$33 | -5 | -45% |
|
|
14
Bank of America
Charlotte,
North Carolina
| – | -$1K | -140 | Closed |
|
|
15
Simplex Trading
Chicago,
Illinois
| – | -$130 | -20 | -23% |
|
LMNL Hedge Fund Activity: Q2 2022 in Review
19 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q2 2022, worth a combined $167K — down 33% from $250K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LMNL positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $20.2K. The largest seller was Bank of America, exiting entirely with an estimated $1K sold.
- 19 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q2 2022, up from 18 in Q1 2022.
- Funds reported $167K of Liminal BioSciences Inc. Common Shares stock for Q2 2022, down 33% quarter-over-quarter.
- 2 funds opened new Liminal BioSciences Inc. Common Shares positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q2 2022 was Renaissance Technologies, an estimated $20.2K added.
- The largest Liminal BioSciences Inc. Common Shares seller in Q2 2022 was Bank of America, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2022.